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Cell cycle: To differentiate or not to differentiate?
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Developmental regulation of the cell cycle is an
important determinant of tissue size and shape. Equally
important is regulated withdrawal from the cell cycle to
allow cells to differentiate. Recent evidence supports a
direct link between transcriptional regulation of the cell
cycle machinery and cell differentiation.
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We often think of cell-cycle progression and differentiation
as two distinct and mutually exclusive processes during
development. When cells continue to cycle they do not dif-
ferentiate, and when cells terminally differentiate they no
longer cycle. Thus, there is a temporal coupling between
withdrawal from the cell cycle and differentiation. But
what are the mechanisms that achieve such coupling?
Several recent studies have provided new insights into this
issue. In one instance, from Drosophila, the same transcrip-
tion factor appears to simultaneously stimulate both cell-
cycle arrest and neural differentiation [1]. 
Our current knowledge of cell-cycle regulation provides a
foundation upon which we can build mechanistic connec-
tions between cell division and terminal differentiation.
Progression through the cell cycle is governed mainly by
the activation and deactivation of a collection of cyclin-
dependent kinases (Cdks), which control specific regula-
tory steps in the cell cycle such as the G1–S and G2–M
transitions. In order for cell cycle arrest to accompany
differentiation, it is necessary either to downregulate
positive regulators of Cdks, such as the cyclins, or to
activate negative regulators of Cdks, such as Cdk
inhibitors. As we discuss below, cells have been found to
use each of these general mechanisms.
Experimental manipulation of cell-cycle regulators allows
one to directly address causality when examining connec-
tions between the cell cycle and differentiation. Although
a temporal coupling of cell-cycle arrest and terminal
differentiation is common during development, and
therefore may seem obligatory, let us first explore whether
there are instances when the two events can be uncou-
pled. It is easy to imagine that arresting the cell cycle
would permit a cell to begin the differentiation process.
Accordingly, it seems unlikely that a typical cell could
terminally differentiate and subsequently re-enter the cell
cycle. But differentiated myocytes overexpressing the
G1–S activator E2F-1 incorporate bromodeoxyuridine
(BrdU) into nuclei, indicating entry into the S phase of the
cell cycle can still occur in these cells [2]. So differentia-
tion does not necessarily preclude progress through the
cell cycle, suggesting that active maintenance of cell-cycle
arrest is an important aspect of the differentiated state.
Some species have evolved to use this plasticity to their
advantage. Certain amphibians, such as the newt, have the
ability to regenerate lost tissue. In cell culture, differenti-
ated newt myotubes will re-enter the cell cycle in
response to a ligand produced by activation of the
thrombin protease, which is required for blood clotting [3].
This cellular response is likely to be a key aspect of the
limb regenerative capability of these animals.
Conversely, does cell-cycle arrest always result in differen-
tiation? A number of recent experiments indicate that the
answer to this question is no — cell-cycle arrest may be
necessary for differentiation, but it is not always sufficient.
Oligodendrocyte differentiation involves both changes in
gene expression and concurrent cell cycle arrest. In order
to determine whether cell-cycle arrest is sufficient to
cause differentiation, Tang et al. [4] inhibited proliferation
of oligodendrocyte precursors in vitro by overexpressing
p27, a well-known Cdk inhibitor. They discovered that
the precursors stopped dividing, but did not express
proteins associated with differentiation. This suggests that
cell-cycle arrest per se is not sufficient for differentiation,
and that other signaling pathways are also needed.
Interestingly, these other signaling pathways can also be
regulated by molecules that are better known to control the
cell cycle. For instance, the Xenopus Cdk inhibitor p27Xic1
was found to induce Müller glial cells in the developing
retina [5]. In this case, one might expect that this cell-cycle
regulator was acting simply to terminate the cell cycle,
thereby allowing the determination of glial cells from
retinoblasts. But cell-cycle arrest caused by treatment of
Xenopus embryos with the DNA synthesis inhibitors
hydroxyurea or aphidicolin was not sufficient to promote
differentiation of retinoblasts into glia. Similarly, dominant-
negative forms of Cdk2 and Cdc2 did not induce glia. It
seems, therefore, that p27Xic1 induces Müller glial cell for-
mation not solely by preventing cell-cycle progression, but
by inducing other targets that affect cell differentiation.
In order to understand how the coordination of cell-cycle
arrest and differentiation is achieved, it would be useful to
bb10h07.qxd  04/17/2000  12:51  Page R302
identify known developmental regulators or pathways that
directly link these two events. An excellent example is
provided by the transcription factor Prospero, which plays
an important role in the developing Drosophila central
nervous system (CNS) [1]. The Drosophila CNS develops
from a group of stem cells called neuroblasts, which
produce specific neurons or glia depending on the neuro-
blast’s position within the embryo. Neuroblasts divide
asymmetrically, giving rise to another neuroblast and a
smaller cell called a ganglion mother cell. Each ganglion
mother cell divides once, producing two daughters that
then differentiate into neurons or glia (Figure 1). Prospero
is produced by neuroblasts, but is asymmetrically located
within the neuroblast mother such that it is specifically
inherited by the daughter ganglion mother cell following
mitosis and cytokinesis of the neuroblast (Figure 1).
In the ensuing ganglion mother cell interphase, Prospero
is translocated to the nucleus, where it is thought to direct
gene expression that results in differentiation of the two
daughters generated by ganglion mother cell division.
Prospero is found only transiently in the nucleus of
newborn neurons, and is not present in mature neurons.
Prospero’s role in specifying neuronal cell fates in the
Drosophila CNS is well-documented. As the movement of
Prospero into the nucleus of the ganglion mother cell co-
incides with the cell’s decision to exit the cell cycle and
terminally differentiate following mitosis (Figure 1), Li
and Vaessin [1] analyzed Prospero’s role in regulating
mitotic activity in the CNS. If cell-cycle arrest and differ-
entiation are truly coupled, one would expect that cells
prevented from differentiating would continue to cycle.
Indeed, prospero mutant embryos contain ectopic mitotic
activity throughout the CNS. The converse is also true:
ectopic mis-expression of prospero precociously arrests cell
division. One of Prospero’s roles in CNS development is
thus to control cell-cycle progression.
But how does Prospero achieve such control? Prospero is a
transcription factor, and regulated gene expression is
known to play an important role in cell-cycle control.
Vassein and Li [1] therefore examined the expression of
various genes encoding cell-cycle regulators after genetic
manipulation of Prospero function. They found that
prospero mutants display inappropriately increased levels
of cycA, cycE, and cdc25string RNAs, all of which encode
stimulators of cell division. Conversely, when prospero is
overexpressed, the same cell-cycle regulatory genes are
now transcriptionally suppressed. Thus, there is a striking
correlation between Prospero’s ability to modulate the
expression of cell-cycle regulators and its ability to affect
cell-cycle progression.
These data suggest a model in which Prospero functions
both to terminate cell proliferation by transcriptional sup-
pression of cell-cycle activators and simultaneously to
induce a differentiation program, effectively coupling the
two events. Despite the appeal of this model, cause and
effect still remain to be firmly established. This is
because most positive regulators of the cell cycle are
usually downregulated during differentiation. Conse-
quently, the correlation between transcriptional shut
off and cell-cycle exit could be just that — a correla-
tion — rather than a mechanism for terminating prolifera-
tion. For instance, a curious result that seems at odds with
the model is that the Drosophila homolog of the
retinoblastoma protein (pRb), a well known negative reg-
ulator of the cell cycle, is also transcriptionally downregu-
lated in response to Prospero activity. Studies aimed at
determining how directly Prospero regulates the tran-
scription of these cell-cycle regulators — for example,
does it bind to upstream control elements of target genes
— should be informative.
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Figure 1
Prospero regulates cell cycle exit in the Drosophila CNS. Drosophila
neuroblast stem cells (NBs) and ganglion mother cells (GMCs) divide via
a rapid, G2-regulated cell cycle that lacks a recognizable G1 phase.
Prospero protein, shown in red, is synthesized by neuroblasts and
localized to the cell cortex. Cytokinesis of the neuroblast occurs in such a
way that Prospero is deposited exclusively into the daughter ganglion
mother cell, and not the regenerated daughter neuroblast. During
interphase of a ganglion mother cell, Prospero translocates to the
nucleus, where it enacts a transcription program that initiates neural
differentiation. Prospero also induces G1 cell-cycle arrest in the two
daughter cells generated by ganglion mother cell division, and this occurs
at least in part from transcriptional downregulation of cell-cycle activators.
bb10h07.qxd  04/17/2000  12:51  Page R303
R304 Current Biology Vol 10 No 8
A different mechanism through which developmentally
important transcription factors can stimulate cell-cycle
arrest is through the induction of Cdk inhibitors. There is
some evidence for this, both from in vitro cell culture
studies and from genetic analyses in animals. For
example, in double mutant mice lacking the function of
both the p21 and p27kip1 Cdk inhibitors, numerous cell
types fail to differentiate during embryonic development
[6,7]. Muscle formation is dramatically affected; myoblasts
cannot properly withdraw from the cell cycle in response
to differentiation signals and consequently overproliferate
[7]. As with the Xenopus Müller glia described above, Cdk
inhibitors may also play a direct role in stimulating differ-
entiation. In myoblasts, p27kip1 activates pRb, which is
inhibited by Cdk-mediated phosphorylation. The pRb
protein is thought to act as a transcriptional cofactor with
myogenic transcription factors, such as MyoD and
myogenin. Although the signals that activate p21 and
p27kip1 during muscle differentiation remain unknown,
these Cdk inhibitors clearly provide a crucial link between
cell-cycle arrest and muscle differentiation.
As in Drosophila, cell-type specific transcription factors
that act in the mammalian nervous system may provide a
way of linking cell-cycle arrest and differentiation. Neural
basic helix-loop-helix (bHLH) transcription factors are
capable of driving neural differentiation when transiently
expressed in a pluripotent cell line [8]. These same
bHLH proteins also initiate cell-cycle withdrawal, as
evidenced by decreased BrdU incorporation, and induce
elevated levels of the Cdk inhibitor p27Kip1. It thus
appears that, within the nervous system, there is direct
communication between factors affecting differentiation
and key components of the cell cycle machinery.
Additional evidence for transcriptional regulation as a
mechanism for controlling the cell cycle during differentia-
tion has also come from work on the nematode Caenorhabdi-
tis elegans. The C. elegans cki-1 gene encodes a member of
the CIP/KIP family of Cdk inhibitors and links postembry-
onic developmental decisions to cell-cycle decisions [9].
The cki-1 gene is expressed in both differentiating cells and
postembryonic cells arrested in G1. Studies using constructs
encoding fusion proteins between Cki-1 and the green fluo-
rescent protein (GFP) showed that the 5′ upstream
sequences of the cki-1 gene governed these patterns of
expression, indicative of transcriptional control. In vivo inhi-
bition of cki-1 function by RNA-mediated interference
(RNAi) in some cases caused a failure both to withdraw
from the cell cycle and to differentiate. Genetic analysis has
implicated several well known signaling pathways in the
regulation of cki-1; these pathways may provide the direct
link between cell-cycle arrest and terminal differentiation. 
Placing cell-cycle arrest and terminal differentiation under
the control of a single developmental regulator, such as
Drosophila Prospero, seems like an efficient and effective
way of making these two processes occur concomitantly
when necessary. There are, however, almost certainly
many other cell-type-specific mechanisms for coordinating
these two events that are still to be discovered. Moreover,
with increasing complexity of the developmental system,
the simple Prospero type of mechanism may not suffice.
This is hinted at in a recent paper describing isoforms of
human Numb protein [10]. Numb was originally identi-
fied in Drosophila, where it acts as a cell-fate determinant
in the peripheral nervous system during asymmetric cell
division, much like Prospero. Verdi et al. [10] found that
distinct isoforms of human Numb regulate either differen-
tiation or proliferation, but not both simultaneously. Thus,
a basic mechanism for coupling differentiation and cell
cycle may have been modified during evolution to provide
new means of regulation in more complex animals. Only
through further experimentation in many different experi-
mental systems will we discover how different regulatory
mechanisms create direct links between the cell cycle and
differentiation during development.
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